Partitioning the Genomic Components of Behavioral Disinhibition and Substance Use (Disorder) Using Genomic Structural Equation Modeling
- 9 July 2024
- journal article
- research article
- Published by Springer Nature in Behavior Genetics
- Vol. 54 (5) , 386-397
Abstract
Externalizing behaviors encompass manifestations of risk-taking, self-regulation, aggression, sensation-/reward-seeking, and impulsivity. Externalizing research often includes substance use (SUB), substance use disorder (SUD), and other (non-SUB/SUD) “behavioral disinhibition” (BD) traits. Genome-wide and twin research have pointed to overlapping genetic architecture within and across SUB, SUD, and BD. We created single-factor measurement models—each describing SUB, SUD, or BD traits—based on mutually exclusive sets of European ancestry genome-wide association study (GWAS) statistics exploring externalizing variables. We then assessed the partitioning of genetic covariance among the three facets using correlated factors models and Cholesky decomposition. Even when the residuals for indicators relating to the same substance were correlated across the SUB and SUD factors, the two factors yielded a large correlation (rg = 0.803). BD correlated strongly with the SUD (rg = 0.774) and SUB (rg = 0.778) factors. In our initial decompositions, 33% of total BD variance remained after partialing out SUD and SUB. The majority of covariance between BD and SUB and between BD and SUD was shared across all factors, and, within these models, only a small fraction of the total variation in BD operated via an independent pathway with SUD or SUB outside of the other factor. When only nicotine/tobacco, cannabis, and alcohol were included for the SUB/SUD factors, their correlation increased to rg = 0.861; in corresponding decompositions, BD-specific variance decreased to 27%. Further research can better elucidate the properties of BD-specific variation by exploring its genetic/molecular correlates.Keywords
All Related Versions
Funding Information
- National Institute on Drug Abuse (T32 DA017637, T32 DA017637, R01 DA053693, R01 DA053693)
- National Institute of Mental Health (R01 MH120219, R01 MH120219)
- National Institute of Aging (RF1 MH120219)
This publication has 36 references indexed in Scilit:
- Evidence for strong genetic correlations among internalizing psychopathology and related self-reported measures using both genomic and twin/adoptive approaches.Journal of Psychopathology and Clinical Science, 2024
- Pervasive Downward Bias in Estimates of Liability-Scale Heritability in Genome-wide Association Study Meta-analysis: A Simple SolutionBiological Psychiatry, 2022
- A large-scale genome-wide association study meta-analysis of cannabis use disorderThe Lancet Psychiatry, 2020
- Association of OPRM1 Functional Coding Variant With Opioid Use DisorderJAMA Psychiatry, 2020
- Genome-wide Association Studies in Ancestrally Diverse Populations: Opportunities, Methods, Pitfalls, and RecommendationsCell, 2019
- Racial/Ethnic Disparities in Pain Burden and Pain Management in the Context of Opioid Overdose RiskCurrent Epidemiology Reports, 2019
- Genome-wide association study across European and African American ancestries identifies a SNP in DNMT3B contributing to nicotine dependenceMolecular Psychiatry, 2017
- Neurobiology of addiction: a neurocircuitry analysisThe Lancet Psychiatry, 2016
- The boundaries of the internalizing and externalizing genetic spectra in men and womenPsychological Medicine, 2013
- Externalizing psychopathology in adulthood: A dimensional-spectrum conceptualization and its implications for DSM-V.Journal of Abnormal Psychology, 2005